Redirecting to https://www.ipsen.com/press-releases/ipsens-onivyde-regimen-a-potential-new-standard-of-care-first-line-therapy-in-metastatic-pancreatic-adenocarcinoma-approved-by-fda/...

Click here if your browser doesn't automatically take you to this page.